Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke | Zendy

Phyo Kyaw Myint | Zendy; Anne S. Hellkamp | Zendy; Gregg C. Fonarow | Zendy; Matthew J. Reeves | Zendy; Lee H. Schwamm | Zendy; Phillip J. Schulte | Zendy; Ying Xian | Zendy; Robert E. Suter | Zendy; Deepak L. Bhatt | Zendy; Jeffrey L. Saver | Zendy; Eric D. Peterson | Zendy; Eric E. Smith | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Prior Antithrombotic Use Is Associated With Favorable Mortality and Functional Outcomes in Acute Ischemic Stroke

Author(s) -

Phyo Kyaw Myint,

Anne S. Hellkamp,

Gregg C. Fonarow,

Matthew J. Reeves,

Lee H. Schwamm,

Phillip J. Schulte,

Ying Xian,

Robert E. Suter,

Deepak L. Bhatt,

Jeffrey L. Saver,

Eric D. Peterson,

Eric E. Smith

Publication year - 2016

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.115.012414

Subject(s) - medicine , antithrombotic , stroke (engine) , modified rankin scale , odds ratio , fibrinolytic agent , confidence interval , ambulatory , ischemic stroke , emergency medicine , cardiology , intensive care medicine , physical therapy , ischemia , mechanical engineering , engineering

Antithrombotics are the mainstay of treatment in primary and secondary prevention of stroke, and their use before an acute event may be associated with better outcomes.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research